Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

MGI Announces Partnership with NGeneBio

Wednesday, August 23, 2023

MGI and NGeneBio have recently entered into a memorandum of understanding (MOU) with the aim of expanding the global availability of NGeneBio's cancer testing products.

This collaboration involves leveraging NGeneBio's advanced NGS (Next-Generation Sequencing) cancer precision diagnosis products on MGI's sequencing platform, specifically the DNBSEQ-G99. This partnership will grant healthcare professionals access to a robust and dependable tool for precision diagnosis and personalised treatment.

NGeneBio and MGI are collaborating to develop an integrated precision diagnostic platform with the goal of improving the accuracy and efficiency of diagnostic tests. This partnership also involves regional clinical trials and collaborations in the Asia-Pacific (APAC) region, aimed at expanding the accessibility and utilisation of advanced NGS solutions.

This strategic partnership brings together NGeneBio's advanced diagnostic assays and MGI's high-throughput sequencing technology. The goal is to accelerate the development and application of innovative sequencing products within the realm of precision medicine. This advancement aims to provide patients with greater access to accurate diagnostics and personalised treatment options.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024BIOVIA from Molecule to MedicineCPHI China || PMEC China 2024Advance DoE WorkshopAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024